Search Results - "Mulwa, Lucky S"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Antiviral Compounds from Myxobacteria by Mulwa, Lucky S, Stadler, Marc

    Published in Microorganisms (Basel) (19-07-2018)
    “…Viral infections including human immunodeficiency virus (HIV), cytomegalovirus (CMV), hepatitis B virus (HBV), and hepatitis C virus (HCV) pose an ongoing…”
    Get full text
    Journal Article
  2. 2

    Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola by Mulwa, Lucky S, Jansen, Rolf, Praditya, Dimas F, Mohr, Kathrin I, Wink, Joachim, Steinmann, Eike, Stadler, Marc

    Published in Molecules (Basel, Switzerland) (28-02-2018)
    “…Two new secondary metabolites, labindole A [2-methyl-3-(2-nitroethyl)-3H-indole] ( ) and labindole B [2-methyl-3-(2-nitrovinyl)-3H-indole] ( ), were isolated…”
    Get full text
    Journal Article
  3. 3

    Lanyamycin, a macrolide antibiotic from Sorangium cellulosum , strain Soce 481 (Myxobacteria) by Mulwa, Lucky S, Jansen, Rolf, Praditya, Dimas F, Mohr, Kathrin I, Okanya, Patrick W, Wink, Joachim, Steinmann, Eike, Stadler, Marc

    Published in Beilstein journal of organic chemistry (26-06-2018)
    “…Lanyamycin ( / ), a secondary metabolite occurring as two epimers, was isolated from the myxobacterium , strain Soce 481. The structures of both epimers were…”
    Get full text
    Journal Article